Interplay of strain and ethnicity in the immune response to M. tuberculosis

描述（由申请方提供）：结核分枝杆菌的基因分型表明，特定的地理区域由结核分枝杆菌的遗传上不同的基因型主导。这种菌株的全球分布，例如北京家庭，可能不是随机的，也不是仅仅基于毒力，社会经济学或地理，而是可能部分由宿主和微生物的遗传学决定，这两者都受到环境和自然选择的影响。在这个提议中，我们假设这种力量在宿主和微生物的共同进化中发挥了作用，因此对于特定的M菌株存在种族特异性的易感性和抗性。结核考虑到感染M.结核病似乎因种族背景而异，在东道国以外的城市环境中，注意到特定种族背景和特定菌株之间有很强的关联。在本文提出的研究中，我们将测量和比较来自不同种族的受试者的细胞响应于不同M菌株的裂解物而产生的细胞因子库。结核分枝杆菌，以确定各种菌株的能力。结核病逃避保护性先天和适应性免疫机制-可能通过选择性诱导抗炎细胞因子。我们计划通过评价健康人供体巨噬细胞对北京菌株（HN 878）、马尼拉菌株（T31）、美国分离的临床菌株（CDC 1551）和实验室参考菌株（H37 Rv）的免疫应答，以及通过评价这些相同菌株在综合全血测定中的作用来实现这一目标。我们将按种族对供者进行分层，寻找是否存在对不同M菌株的种族特异性免疫遗传易感性。结核本研究的目的是确定是否遗传多样性菌株的M。结核病在选定的种族之间诱导不同的先天性和适应性反应，从而为针对特定人群定制疫苗铺平了道路。我组建了一个由国际公认的科学家组成的指导委员会，这些科学家在结核病研究方面有着良好的记录，特别是在分子基因分型（Philip Hopewell博士-主要导师）和M.结核病，混合物分析（Neil Risch博士）和流行病学（Dennis Osmond和Neil Risch博士）。总之，这些高级研究人员代表了对我的培训和拟议的研究学习至关重要的领域的多样性。

DESCRIPTION (provided by applicant): Genotyping of Mycobacterium tuberculosis has shown that specific geographic regions are dominated by genetically distinct genotypes of Mycobacterium tuberculosis. This global distribution of strains, such as that seen with the Beijing family, may not be random or solely based upon virulence, socioeconomics, or geography but may be partly determined by the genetics of the host and the microbe, both of which are under environmental and natural selection forces. In this proposal, we hypothesize that such forces have played a role in the co-evolution of host and microbe, such that ethnic-specific susceptibility and resistance exists for particular strains of M. tuberculosis. This interplay between the strain and the ethnic background of the host is plausible, given that susceptibility to and outcome of infection with M. tuberculosis appears to vary with ethnic background and that a strong association between specific ethnic backgrounds and specific strains has been noted in urban settings outside of the host's native country. In the research proposed herein, we will measure and compare the cytokine repertoire produced by cells from subjects of different ethnicities in response to lysates of different strains of M. tuberculosis to determine the ability of various strains of M. tuberculosis to evade protective innate and adaptive immune mechanisms - possibly by selective induction of anti-inflammatory cytokines. We plan to accomplish this by evaluating the immune response of healthy human donor macrophages to a Beijing strain (HN878), a Manila strain (T31), a clinical strain isolated in the US (CDC1551), and a laboratory reference strain (H37Rv), as well as by evaluating the effect of these same strains in an integrative, whole blood assay. We will stratify the donors by ethnicity, looking for the presence of ethnic-specific immunogenetic predisposition to distinct strains of M. tuberculosis. This research aims to establish whether the genetically diverse strains of M. tuberculosis induce different innate and adaptive responses amongst and between select ethnicities, and thus pave the way for tailoring vaccines to specific populations. I have assembled a mentoring committee of internationally recognized scientists with strong track records in the study of tuberculosis, particularly in molecular genotyping (Dr. Philip Hopewell - primary mentor) and immunology (Dr. David Lewinsohn) of M. tuberculosis, and in admixture analysis (Dr. Neil Risch) and epidemiology (Drs. Dennis Osmond and Neil Risch). Together, these senior investigators represent the diversity of fields that are essential for my training and proposed research study.